Yarbrough Capital’s Abiomed Inc ABMD Stock Holding History

Yarbrough Capital’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,212	Closed	-$298K	–	247
2022 Q3	$298K	Hold	1,212	–	–	0.02%	158
2022 Q2	$300K	Hold	1,212	–	–	0.02%	147
2022 Q1	$401K	Hold	1,212	–	–	0.02%	164
2021 Q4	$435K	Buy	+1,212	New	+$409K	0.02%	149

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Yarbrough Capital's ABMD Position: Q4 2022 in Review

Yarbrough Capital sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,212 shares — an estimated $298K sold.

Yarbrough Capital first reported a position in ABMD in Q4 2021 and held it in 4 quarters. The position peaked at $435K in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Yarbrough Capital reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Yarbrough Capital sold 1,212 Abiomed Inc shares in Q4 2022, an estimated $298K.
Yarbrough Capital first reported a position in Abiomed Inc in Q4 2021 and held it in 4 quarters.
Yarbrough Capital's Abiomed Inc position peaked at $435K in Q4 2021.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Yarbrough Capital's 13F filing for Q4 2022, filed 12 Jan 2023.